Cargando…

Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study

Nafamostat mesylate may be effective against coronavirus disease 2019 (COVID-19). However, it is not known whether its use is associated with reduced in-hospital mortality in clinical practice. We conducted a retrospective observational study to evaluate the effect of nafamostat mesylate in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inokuchi, Ryota, Kuno, Toshiki, Komiyama, Jun, Uda, Kazuaki, Miyamoto, Yoshihisa, Taniguchi, Yuta, Abe, Toshikazu, Ishimaru, Miho, Adomi, Motohiko, Tamiya, Nanako, Iwagami, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745709/ https://www.ncbi.nlm.nih.gov/pubmed/35011857 http://dx.doi.org/10.3390/jcm11010116

Ejemplares similares

Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
por: Watanabe, Atsuyuki, et al.
Publicado: (2023)

Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017–2020: a multicenter, retrospective cohort study in Japan
por: Taniguchi, Yuta, et al.
Publicado: (2022)

Characteristics and in-hospital mortality of patients with COVID-19 from the first to fifth waves of the pandemic in 2020 and 2021 in the Japanese Medical Data Vision database
por: Suzuki, Toshiki, et al.
Publicado: (2023)

Development and validation of a risk score to predict the frequent emergency house calls among older people who receive regular home visits
por: Sun, Yu, et al.
Publicado: (2022)

Factors associated with undertriage in patients classified by the need to visit a hospital by telephone triage: a retrospective cohort study
por: Inokuchi, Ryota, et al.
Publicado: (2021)

Factors associated with long-term urinary catheterisation and its impact on urinary tract infection among older people in the community: a population-based observational study in a city in Japan
por: Adomi, Motohiko, et al.
Publicado: (2019)

Evaluation of enhanced home care support clinics regarding emergency home visits, hospitalization, and end-of-life care: a retrospective cohort study in a city of Japan
por: Sun, Yu, et al.
Publicado: (2023)

The role of after-hours house-call medical service in the treatment of COVID-19 patients awaiting hospital admission: A retrospective cohort study
por: Inokuchi, Ryota, et al.
Publicado: (2022)

Machine learning models predicting undertriage in telephone triage
por: Inokuchi, Ryota, et al.
Publicado: (2022)

Association between physicians’ characteristics and their knowledge, attitudes, and practices regarding advance care planning: a cross-sectional study
por: Sakamoto, Ayaka, et al.
Publicado: (2023)

Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
por: Ghali, George Zaki, et al.
Publicado: (2020)

Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
por: Kim, Joo-Hee, et al.
Publicado: (2021)

Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
por: Shioya, Nobuki, et al.
Publicado: (2022)

Regional variation in long-term care spending in Japan
por: Jin, Xueying, et al.
Publicado: (2022)

Retraction: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Publicado: (2021)

Epidemiology of Food Choking Deaths in Japan: Time Trends and Regional Variations
por: Taniguchi, Yuta, et al.
Publicado: (2021)

Changes in the proportion and severity of patients with fever or common cold symptoms utilizing an after-hours house call medical service during the COVID-19 pandemic in Tokyo, Japan: a retrospective cohort study
por: Inokuchi, Ryota, et al.
Publicado: (2021)

Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome
por: Nakamura, Yuta, et al.
Publicado: (2021)

Cytokine expressions of spinal cord injury treated by neurotropin and nafamostat mesylate
por: Sun, Chao, et al.
Publicado: (2021)

AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study
por: Hirayama, Takahiro, et al.
Publicado: (2017)

Comparison of the Characteristics and Outcomes of COVID-19 Patients Treated by a Hospital-at-Home Service in Japan during the Alpha and Delta Waves
por: Inokuchi, Ryota, et al.
Publicado: (2022)

Association between off-hour admission of critically ill children to intensive care units and mortality in a Japanese registry
por: Kido, Takahiro, et al.
Publicado: (2021)

Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
por: Hifumi, Toru, et al.
Publicado: (2020)

Regional Inequality in Dental Care Utilization in Japan: An Ecological Study Using the National Database of Health Insurance Claims
por: Taira, Kento, et al.
Publicado: (2021)

The Effect of Business Operating Systems on Nursing Home Termination
por: Jin, Xueying, et al.
Publicado: (2023)

Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate
por: Osawa, Itsuki, et al.
Publicado: (2020)

Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review
por: Hernández-Mitre, María Patricia, et al.
Publicado: (2022)

Application of nafamostat mesylate for anticoagulation in hemoperfusion therapy in patients with bromadiolone poisoning: Case reports
por: Qian, Weiwei, et al.
Publicado: (2023)

Surgical mask use by healthcare personnel to prevent COVID‐19 spread in a long‐term care facility
por: Abe, Toshikazu, et al.
Publicado: (2020)

The Long-Term Care Insurance System in Japan: Past, Present, and Future
por: Iwagami, Masao, et al.
Publicado: (2019)

Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan
por: Suzuki, Toshiki, et al.
Publicado: (2020)

Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports
por: Okajima, Masaki, et al.
Publicado: (2020)

Clinical efficacy of Nafamostat Mesylate in combination with Favipiravir for COVID-19 pneumonia treatment review article
por: Abduljabbar, Maram H.
Publicado: (2021)

Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
por: Kim, Hyeon-A, et al.
Publicado: (2022)

Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition
por: Morimoto, Mari, et al.
Publicado: (2022)

Hospital-Level Variation in Cardiac Rehabilitation After Myocardial Infarction in Japan During Fiscal Years 2014–2015 Using the National Database
por: Komiyama, Jun, et al.
Publicado: (2023)

The Association of Timing of Tracheostomy and Survival of Patients with COVID-19
por: Kuno, Toshiki, et al.
Publicado: (2021)

Barriers to and facilitators of advance care planning implementation for medical staff after the COVID-19 pandemic: an overview of reviews
por: Inokuchi, Ryota, et al.
Publicado: (2023)

Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan
por: Kamijo, Hiroshi, et al.
Publicado: (2020)

Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis
por: Watanabe, Atsuyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7f4fmsll88jcu7n06eq6rrf7ng